PRESS RELEASE

GPI ANNOUNCES CLOSING OF HAEMONETICS' ASSETS ACQUISITION

GPI'S INTERNATIONAL POSITIONING IN THE BLOOD MANAGEMENT SOFTWARE REINFORCED, MORE THAN 100 CLIENTS ACQUIRED IN THE UNITED STATES OF AMERICA

Trento, 2 July 2020

GPI (GPI: IM), a leading company in IT Solutions and Healthcare and Social Services, listed on the MTA market of Borsa Italiana, announces, further to the press release dated May 28, 2020, that yesterday late evening it has completed the acquisition of the assets as stipulated in the contract with HAEMONETICS CORPORATION (NYSE: HAE) signed on on May 28.

Under the terms of the agreement, Haemonetics and its subsidiary Global Med Technologies, Inc. will transfer the intellectual property, customer contracts and certain other assets relating to its ElDorado Donor®, Hemasphere®, Donor Doc®, Donor Doc Phlebotomy®, eDonor®, DonorSpace®, Surround™ and SafeTrace® software products to Gpi USA Inc. a Newco specifically established on June 10 this year, to expand Gpi's business in the U.S. market, within the sector of the management of the entire blood transfusion process. Gpi USA inc. is a subsidary owned 100% by Gpi S.p.A. The closing brings more than U.S. 100 clients to Gpi.

The sector of blood management software is one of the main business lines in Gpi's internationalization process. The Company entered into this market some years ago by the strategic acquisitions of Insiel Mercato (a leader in Italy), Hemasoft Software S.L. (present ion more than 60 countries and already operating in the USA), and Guyot Walser Informatique operating in 360 hospitals in France. On May 25, Gpi signed the agreement for the acquisition of 100% of the Medinfo Group, one player of note in France for the blood management software, composed of 3 companies: Medinfo International Hémoservice, Medical International Hemoservice Limitada Ltda e Chartage Software Sarl. The acquisition of the Medinfo Group widens Gpi's range as it brings clients in France, Saudi Arabia, Qatar, Thailand, United Kingdom, Spain and Belgium.

These acquisitions make Gpi an important global player in the Blood Management Software System, a so crucial sector especially now in the actual pandemic emergency

GPI GROUP

Gpi is the partner of reference for software, technologies and services dedicated to health care, social care and public administration. Founded over 30 years ago in Trento, Italy, Gpi has grown thanks to significant investments in M&A (in Italy and abroad) and R&D, carried out in partnership with the main Italian universities and research organizations with the aim of transferring scientific, technological, functional and process know-how applied to the e-health, e-welfare, well-being sectors. Thanks also to the solutions and the specialised expertise passed on from companies who became part of the Gpi ecosystem, the Group has managed to translate emerging needs from health care into cutting-edge technological solutions and new service models capable of optimizing prevention processes , diagnosis and treatment, improving people's quality of life.

The products combine specialist expertise in IT and consultancy and design skills, which allow Gpi to operate in different business areas: Software, Care, Automation, ICT and Pay.

In 2019 the Company delivered consolidated revenues of 241 million Euros, over 5,300 employees and more than 2,200 customers spread over 60 countries.

In 2016 Gpi was listed on Borsa Italiana AIM market and graduated to MTA market in 2018. ISIN common shares: IT0005221517 - ISIN "Warrant GPI SpA": IT0005221475 Press release at www.Gpi.it and

CONTACTS

Investor Relations

Media Relations

Specialist

Banca Akros | Bruno Mestice | [email protected] | T. +3902434441 | Viale Eginardo, 29 – 20149 Milano

AI Terminal

Gpi

4426_rns_2020-07-02_cd8c33bb-1d03-4ae9-9278-47afa7fec445.pdf